Comparison of quality of life in patients with non-small cell lung cancer treated by chemotherapy or radiotherapy

M. Rancic, S. Rancic, M. Cekic, M. Radovic, T. Pejcic, I. Stankovic, L. Ristic, D. Zivkovic (Nis, Serbia)

Source: Annual Congress 2004 - Complications of lung cancer or its treatment quality of life - prognosis
Session: Complications of lung cancer or its treatment quality of life - prognosis
Session type: Thematic Poster Session
Number: 576
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Rancic, S. Rancic, M. Cekic, M. Radovic, T. Pejcic, I. Stankovic, L. Ristic, D. Zivkovic (Nis, Serbia). Comparison of quality of life in patients with non-small cell lung cancer treated by chemotherapy or radiotherapy. Eur Respir J 2004; 24: Suppl. 48, 576

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Correlation between parameters of quality of life in patients with non-small cell lung cancer treated by chemotherapy and radiotherapy
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007


Influence of dose of radiotherapy on quality of life in patients with non-small cell lung cancer treated by radiotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 495s
Year: 2005

Quality of life in patients with non-small cell lung cancer treated by chemotherapy
Source: Eur Respir J 2003; 22: Suppl. 45, 64s
Year: 2003

Serum tumor markers and quality of life before and after platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2002; 20: Suppl. 38, 74s
Year: 2002

Should patients with metastatic NSCLC and poor performance status be treated by chemotherapy?
Source: Annual Congress 2007 - Treatment of metastatic nonsmall cell lung cancer in the era of targeted therapies
Year: 2007


Impact of neoadjuvant therapy on tumor resectability and survival of patients with locally advanced non-small cell lung cancer
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011


Role of chemotherapy in stage III non-small cell lung cancer (NSCLC): adjuvant or induction?
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Quality of life in patients with advanced forms of NSCLC and breast cancer after induction chemotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005

Locally advanced inoperable non-small cell lung cancer (NSCLC) treated by weekly paclitaxel/carboplatin chemotherapy with concomitant radiotherapy
Source: Eur Respir J 2007; 30: Suppl. 51, 433s
Year: 2007

Survival of elderly patients with non-small lung cancer tretaed with combined chemotherapy and radiotherapy
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

Lung function evaluation in gemcitabine and concurrent radiotherapy treatment in nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2001; 18: Suppl. 33, 376s
Year: 2001

Systematic review of the effect of chemotherapy on quality of life (QoL) and symptom control in patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Lung cancer treatment
Year: 2006


The 7-year results of the surgical treatment of non-small cell lung cancer (NSCLC) patients and the influence of neoadjuvant treatment
Source: Annual Congress 2007 - Therapy of thoracic malignancies
Year: 2007


Treatment of advanced non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005


Salvage surgery in patients with locally advanced non-small cell lung cancer – outcomes and longtime results
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Impact of radiotherapy on outcomes of nivolumab in advanced non-small cell lung cancer: a case controlled study
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018




Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer
Source: ERJ Open Res, 4 (2) 00120-2017; 10.1183/23120541.00120-2017
Year: 2018



Health-related quality of life in elderly patients with advanced non-small cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy
Source: Eur Respir J 2016; 48: 861-872
Year: 2016



The big lung trial (BLT): determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the radical radiotherapy setting
Source: Eur Respir J 2003; 22: Suppl. 45, 163s
Year: 2003

A study comparing the efficacy, quality of life and toxicity of cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer in the Indian scenario
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011